Health·3,538 stories
Residents across the West Country will witness up to 95% of the sun obscured during a rare partial solar eclipse, the most dramatic visible from the UK since 1999, with viewing events and safety guida
Novo Nordisk's anti-inflammatory drug ziltivekimab failed to reduce major cardiovascular events in a Phase 3 heart disease trial enrolling over 6,300 patients, despite successfully lowering inflammati
A total solar eclipse on 12 August will trace a narrow path across the Arctic, northern Russia, Greenland, Iceland, and Spain, with the next major opportunity — a 6-minute-23-second totality over nort
Two researchers defend their 2023 Lancet study on COVID-19 nonpharmaceutical interventions, arguing a recent op-ed by Marc Lipsitch and Sara Cody mischaracterized their work by claiming it failed to a
The FDA's inconsistent application of platform technology designation is blocking a promising LGMD2E/R4 gene therapy from advancing to approval, even as the agency allows the same underlying viral vec
UCSD researchers have identified active syphilis in roughly 10% of unhoused San Diego participants in their latest study, even as NIH restrictions forced them to drop cross-border Tijuana research and
A philosopher-turned-investor argues quantum computers are stuck in a 'perpetual five-year' trap because we don't yet know what one fundamentally is. Christophe Jurczak's year-long paper suggests the
US-based Meteomatics has built Meteobase, an automated ground station that launches and recovers drones to gather weather data from the boundary layer, offering a reusable alternative to helium-depend
Health tech giant CareCloud has begun notifying nearly 350,000 people that hackers accessed one of its patient data stores for six days in March, stealing medical records, Social Security numbers, and
DNA recovered from mummies at a Chilean archaeological site matched European lineages of smallpox, providing the first direct molecular proof that colonizers brought the virus to the Americas.
A new computational method revealed that 0.5–1% of every living person's DNA traces to an unknown 'ghost ancestor' — and because its fragments spread evenly across the genome, scientists could nearly
DNA analysis of 521 woolly mammoth fossils reveals Paleolithic hunters disproportionately targeted females — 70% of specimens at human sites — likely because herd-bound females were slower and more pr
The Senate health committee, led by Chair Bill Cassidy, approved two of President Trump's top public health nominees Thursday, advancing them to a full Senate floor vote expected to confirm them.
Researchers at Imperial College London unveiled MiFi, a foldable bioelectronic sensor inspired by origami that compresses for insertion through a tiny incision, then unfolds beneath the skin to contin
Neuroscientist Christof Koch challenges the assumption that the brain creates consciousness, arguing that it may instead be a fundamental feature of reality, citing unexplained phenomena and theoretic
Unitaid's new report warns that oil price spikes driven by Middle East conflict could raise manufacturing costs for one HIV medication by 15% at $120 per barrel — and 85% of that increase traces back
Toho University researchers found that ferulic acid, a polyphenol in rice bran, suppresses intestinal smooth muscle contractions by blocking voltage-dependent calcium channels, pointing to possible di
An FDA advisory committee met Thursday to evaluate Replimune's engineered viral immunotherapy RP1 for melanoma, a drug the agency had rejected in April under former leaders Marty Makary and Vinay Pras
IBM researchers have demonstrated three new cases of quantum advantage — calculations classical computers can't replicate — alongside new methods to verify how much of each quantum output can actually
Tanruprubart, a monoclonal antibody from Annexon Biosciences, showed strong results in a late-stage Guillain-Barré syndrome trial and could become the first targeted treatment for the autoimmune nerve
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.